Brivaracetam for epilepsy, absence

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Mar 2024: Trial registered, NCT06315322
  2. 10 Jul 2024: Trial started, NCT06315322

The trials

NCT06315322: A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

State
Under way
Phase
Phase 3
People
70 taking part
Started
10 Jul 2024
Primary completion
16 Nov 2029
Arms
Brivaracetam arm
Results
None posted
  1. 18 Mar 2024: Trial registered
  2. 10 Jul 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Brivaracetam Film-coated tablet, Brivaracetam oral solution, Briviact.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.